Information Journal Paper
APA:
Copy. (2018). Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy. CLINICAL IMMUNOLOGY, 190(-), 22-31. SID. https://sid.ir/paper/768071/en
Vancouver:
Copy. Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy. CLINICAL IMMUNOLOGY[Internet]. 2018;190(-):22-31. Available from: https://sid.ir/paper/768071/en
IEEE:
Copy, “Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy,” CLINICAL IMMUNOLOGY, vol. 190, no. -, pp. 22–31, 2018, [Online]. Available: https://sid.ir/paper/768071/en